Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...
Novo’s Ozempic Linked to Reduced Alzheimer’s Diagnoses
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according ...
STAT14m
Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study
In an observational study, Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among ...
Ozempic linked to lower Alzheimer’s risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...
Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
Type 2 diabetics may have a shot at significantly lowering their risk of Alzheimer’s disease if they take Ozempic instead of ...
West Pharmaceutical raises annual profit forecast on demand for medical supplies
The company now expects 2024 profit in the range of $6.55 to $6.75 per share, compared with its previous profit per share forecast of $6.35 to $6.65. The Pennsylvania-based firm has been anticipating ...
ENDPOINTS NEWS1m
No­vo Nordisk pe­ti­tions FDA to stop semaglu­tide com­pound­ing over safe­ty risks
Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...